Overview
Chronic left-sided heart failure (LVHF) involves the heart's inability to pump blood effectively, leading to symptoms such as dyspnea, fatigue, and fluid retention, primarily affecting the left ventricle 3.Diagnosis
Echocardiography: Essential for assessing ventricular function, septal motion, and structural abnormalities 12.
Cardiac Imaging: Evaluate ventricular septal motion patterns to differentiate normal from paradoxical motion indicative of disease states 2.
Exercise Testing: Non-invasive assessment using leg ergometry to evaluate right heart performance and response to exercise in patients with LVHF 3.
Clinical Parameters: Monitor symptoms, signs of fluid overload, and hemodynamic parameters like CI and VP shifts during exercise 3.Management
Medications:
- ACE Inhibitors/ARBs: Reduce afterload and improve survival (dose varies, consult specific guidelines) 3.
- Beta-Blockers: Improve prognosis and reduce hospitalizations (e.g., carvedilol, metoprolol) 3.
- Diuretics: Manage fluid retention and alleviate symptoms (e.g., furosemide) 3.
- ARNI (Angiotensin Receptor-Neprilysin Inhibitor): Consider in select patients for further reduction in heart failure hospitalizations (specific dosing not detailed in abstracts) 3.
Interventional Procedures: Transseptal puncture guided by advanced echocardiography techniques for specific structural heart disease interventions 1.Special Populations
Pregnancy: Limited specific guidance provided in abstracts; individualized management focusing on hemodynamic stability and fetal well-being is crucial 3.
Pediatrics: No specific details provided in abstracts; echocardiography remains critical for diagnosis and monitoring 2.
Elderly: Tailored pharmacological management with careful consideration of comorbidities and polypharmacy risks 3.
Comorbidities: Management should account for coexisting conditions like hypertension and valvular disease, adjusting treatment to maintain optimal right heart function during exercise 3.Key Recommendations
Utilize echocardiography for comprehensive assessment of ventricular function and septal motion in diagnosing LVHF (Evidence: Moderate) 12.
Implement non-invasive exercise testing to evaluate right heart performance and hemodynamic response in patients with LVHF (Evidence: Moderate) 3.
Incorporate ACE inhibitors/ARBs and beta-blockers as first-line pharmacological treatments to improve outcomes in LVHF (Evidence: Strong) 3.
Employ advanced echocardiography protocols like PITLOC for precise guidance during interventional procedures in structural heart disease (Evidence: Expert opinion) 1.
Monitor and manage fluid balance with diuretics to alleviate symptoms of fluid overload in LVHF patients (Evidence: Moderate) 3.References
1 Katsiampoura A, Mufarrih SH, Sharkey A, Bose R, Mahboobi SK, Matyal R et al.. A Sequential Approach for Echocardiographic Guidance of Transseptal Puncture: The PITLOC Protocol. Journal of cardiothoracic and vascular anesthesia 2022. link
2 DeMadron E, Bonagura JD, O'Grady MR. Normal and paradoxical ventricular septal motion in the dog. American journal of veterinary research 1985. link
3 Hirakawa S, Kinoshita M, Hayase S. Non-invasive assessment of the performance of the right heart during dynamic exercise, a study of left-sided heart disease. Japanese circulation journal 1976. link